You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫思健康(02138.HK)擬發行代價股份收購Prime Inspire的7.5%股權
格隆匯 10-02 23:48

格隆匯10月2日丨醫思健康(02138.HK)公佈,於2022年9月30日,買方(Team Expert Investment Limited,為公司全資附屬公司)、公司、該等賣方、CEVL股東及DTHL股東訂立買賣協議,據此,買方有條件同意收購,而該等賣方有條件同意出售目標公司合共7.5%股權,總代價為4,375,515港元,將由公司根據一般授權向CEVL股東及DTHL股東配發及發行入賬列為繳足的合共852,922股代價股份支付。

代價股份相當於(i)公司於公吿日期之現有已發行股本約0.07%;及(ii)本公司經發行代價股份擴大的已發行股本約0.07%(假設除發行代價股份外,公司已發行股本於公吿日期至完成日期期間概無變動)。於公吿日期,目標公司由買方間接擁有70%股權。

據悉,目標公司Prime Inspire Limited為一間於英屬處女羣島註冊成立的有限公司,併為公司的非全資附屬公司。於公吿日期,目標公司由買方(公司的全資附屬公司)、CEVL及DTHL分別擁有70%、9.6%及20.4%的股權。目標公司主要從事提供多渠道網絡服務。

於完成後,公司於目標公司的權益由70%增加至77.5%,而目標公司的財務業績將繼續於集團賬目內綜合入賬。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account